More than 30 years after HIV/AIDS first appeared, there are an estimated 37 million cases worldwide with nearly 70% of HIV positive patients living in Sub Saharan Africa followed by Southeast Asia, Latin America and Eastern Europe. The vast majority of individuals affected by HIV are in low and middle income countries. More than 3 million children were infected by HIV positive mothers during pregnancy and childbirth or through breastfeeding (1).
The worldwide need for effective assessment and treatment is more urgent than ever, and Beckman Coulter is part of the solution. Beckman Coulter helped pioneer the use of flow cytometry to confront the emerging threat of HIV/AIDS in the 1980s. Beckman Coulter introduced the manual CD4 counting test for use with a microscope for labs without access to flow cytometry. Beckman Coulter is moving healthcare forward by bringing more than 80 years of automation and innovation history in the clinical diagnostics laboratory from flow cytometry to the molecular diagnostics arena.